Integrating ART adherence support technologies in the care of pregnant and postpartum people with HIV: a qualitative study. (Record no. 12603)

MARC details
000 -LEADER
fixed length control field 03973nam a22003857a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230626s20222022 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2662-2211
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1186/s43058-022-00331-0 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1186/s43058-022-00331-0 [pii]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC9344442 [pmc]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 35918738
245 ## - TITLE STATEMENT
Title Integrating ART adherence support technologies in the care of pregnant and postpartum people with HIV: a qualitative study.
251 ## - Source
Source Implementation Science Communications. 3(1):85, 2022 Aug 02.
252 ## - Abbreviated Source
Abbreviated source Implement. sci. commun.. 3(1):85, 2022 Aug 02.
253 ## - Journal Name
Journal name Implementation science communications
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2022
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2023
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Publication date 2022 Aug 02
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status epublish
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Medline status PubMed-not-MEDLINE
266 ## - Date added to catalog
Date added to catalog 2023-06-26
520 ## - SUMMARY, ETC.
Abstract BACKGROUND: We have a limited understanding on how to best integrate technologies to support antiretroviral therapy (ART) adherence in routine HIV care.
520 ## - SUMMARY, ETC.
Abstract CONCLUSIONS: Our study elucidates barriers and facilitators to integrating technology-based adherence support approaches in clinical care to support adherence of pregnant and postpartum people with HIV. Copyright © 2022. The Author(s).
520 ## - SUMMARY, ETC.
Abstract METHODS: We conducted semi-structured interviews with multidisciplinary providers caring for pregnant and postpartum people with HIV and asked providers about their perspectives on utilizing adherence support technologies such as text messages, video check-ins with providers or automated with facial recognition for directly-observed-therapy, signaling pill bottle, and signaling pill to support ART adherence. Each approach generated an adherence report. The interview instrument was guided by the Consolidated Framework for Implementation Research and included questions on the implementation climate, barriers, and facilitators to the clinical integration of the adherence approach and strategies that could be used to maximize this integration. The order of adherence support technologies was randomized to minimize bias. We used a modified grounded theory to develop the coding structure and two coders applied the codebook to the transcripts after establishing strong inter-rater reliability with 20% of interviews (kappa = 0.82).
520 ## - SUMMARY, ETC.
Abstract RESULTS: Between March and December 2020, we conducted 26 in-depth, semi-structured interviews with providers who weighed several factors when considering each approach, including the approach's effect on patient-provider interaction in and outside of the clinic visit, timing for and duration of the approach's utility, threat of disclosing status, and added burden to providers (e.g., needing to act on generated information) or to patients (e.g., needing to hide the signaling pills, responding to text messages). Providers' most preferred approach was text-messages, and the least preferred was the signaling pill. Barriers to acceptability varied by approach and included perceived surveillance, violation of privacy, added time demand for providers, potential inaccuracy of the adherence data generated, and negative impact on the patient-provider relationship, particularly if the approach was perceived as coercive. Payers anticipated regulatory hurdles with unfamiliar approaches, particularly the signaling pill and signaling pill bottle. Facilitators included strengthened therapeutic alliance, predictable reminder mechanisms, and options for customization according to patient preference.
546 ## - LANGUAGE NOTE
Language note English
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Obstetrics and Gynecology
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Scott, Rachel
Institution Code MWHC
790 ## - Authors
All authors Rendell S, Schmidt H, Neergaard R, Nkwihoreze H, Barbati Z, Short WR, Rana AI, Sheth AN, Scott RK, Sethi S, Momplaisir FM
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1186/s43058-022-00331-0">https://dx.doi.org/10.1186/s43058-022-00331-0</a>
Public note https://dx.doi.org/10.1186/s43058-022-00331-0
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 06/26/2023   35918738 35918738 06/26/2023 06/26/2023 Journal Article

Powered by Koha